Novocure (Nasdaq:NVCR) announced today that it submitted an FDA premarket approval (PMA) application for its tumor-treating ...

Signos announced today that it launched its FDA-cleared over-the-counter glucose monitoring system for weight management.

“Our decision to become one of Medtronic’s largest investors was driven by our strong conviction that the company is entering ...

Irvine, California-based Edwards triggered the agreement to repurchase $500 million of its common stock. With this ...

Pleural Dynamics announced today that it completed enrollment in a post-market clinical study for its ACES system.

Stimvia announced that it completed a clinical study of its peroneal electrical transcutaneous neurmodulation (peroneal eTNM) ...

Masimo (Nasdaq: MASI) announced today that it received FDA 510(k) clearance for expanded indications for its O3 regional ...